Extending the case for oestradiol in androgen-sensitive prostate cancer - Authors' reply

Lancet Oncol. 2013 Jun;14(7):e253. doi: 10.1016/S1470-2045(13)70203-1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Drug-Related Side Effects and Adverse Reactions*
  • Estrogens / administration & dosage*
  • Humans
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Receptors, LHRH / administration & dosage*

Substances

  • Estrogens
  • Receptors, LHRH